Work

First results of aponermin(Apo) improving teclistamab (tec)/talquetamab (tal) in patients (pts) with Relapsed/Refractory multiple myeloma (RRMM)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7576

Authors: Lefu Huang, Yuechen Zhang, Huijuan Wang, Wenjing Li, Yanru Zhang, Menghan Liu, Ying Tian, Zunmin Zhu, Hong-Hu Zhu, Wenming Chen, Aijun Liu

Institutions: Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou People's Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417013279

Cites:

Cited by:

Related to: